Evidence map›Paper›PMID 30839958›Full record

ArticleThe Analyst2019

A comparison of mid-infrared spectral regions on accuracy of tissue classification.

Shachi Mittal, Rohit Bhargava

Abstract read
In one paragraph

Article in The Analyst, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Digital Histopathology by Infrared Spectroscopic Imaging.Annual review of analytical chemistry (Palo Alto, Calif.) · 2023
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shachi MittalDepartment of Bioengineering and Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. rxb@illinois.edu.
Rohit Bhargava

Funding

Discrete Frequency Infrared Spectroscopic Imaging for Breast HistopathologyR01EB009745 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BHARGAVA, ROHIT · 2010 to 2025
$5.1M
NIBIB NIH HHS R01 EB009745
6 · The paper itself

Abstract

Infrared (IR) spectroscopic imaging, utilizing both the molecular and structural disease signatures, enables extensive profiling of tumors and their microenvironments. Here, we examine the relative merits of using either the fingerprint or the high frequency regions of the IR spectrum for tissue histopathology. We selected a complex model as a test case, evaluating both stromal and epithelial segmentation for various breast pathologies. IR spectral classification in each of these spectral windows is quantitatively assessed by estimating area under the curve (AUC) of the receiver operating characteristic curve (ROC) for pixel level accuracy and images for diagnostic ability. We found only small differences, though some that may be sufficiently important in diagnostic tasks to be clinically significant, between the two regions with the fingerprint region-based classifiers consistently emerging as more accurate. The work provides added evidence and comparison with fingerprint region, complex models, and previously untested tissue type (breast) - that the use of restricted spectral regions can provide high accuracy. Our study indicates that the fingerprint region is ideal for epithelial and stromal models to obtain high pixel level accuracies. Glass slides provide a limited spectral feature set but provides accurate information at the patient level.

Indexed as

BreastCarcinoma, Ductal, BreastCarcinoma, LobularConnective TissueEpitheliumHumansHyperplasiaModels, BiologicalROC CurveSpectrophotometry, Infrared

Identifiers

PMID30839958
PMCPMC6453738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.